A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The stromal microenvironment and particularly the macrophage component of primary tumors influence their malignant potential. However, at the metastatic site the role of these cells and their mechanism of actions for establishment and growth of metastases remain largely unknown. METHODOLOGY/PRINCIPAL FINDINGS: Using animal models of breast cancer metastasis, we show that a population of host macrophages displaying a distinct phenotype is recruited to extravasating pulmonary metastatic cells regardless of species of origin. Ablation of this macrophage population through three independent means (genetic and chemical) showed that these macrophages are required for efficient metastatic seeding and growth. Importantly, even after metastatic growth is established, ablation of this macrophage population inhibited subsequent growth. Furthermore, imaging of intact lungs revealed that macrophages are required for efficient tumor cell extravasation. CONCLUSION/SIGNIFICANCE: These data indicate a direct enhancement of metastatic growth by macrophages through their effects on tumor cell extravasation, survival and subsequent growth and identifies these cells as a new therapeutic target for treatment of metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Clinical studies and experimental animal models suggest that TAM commonly plays a pro-tumoral role in various ways [89, 96, 97].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,374
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“They probably differentiate from monocytes precursors that are restricted to blood and seed most macrophages but it cannot be ruled out that they cross-differentiate from other resident macrophages as has been described in some immune responses [61].”
BackgroundDissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911 · cited 2×
“This ability of tumor cells to establish themselves at the metastatic site is considered one of the major rate limiting steps in metastasis [1].”
BackgroundMicroenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 2×
“no direct evidence for macrophages influencing the events subsequent to homing of metastatic cells [22].”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“This metastasisassociated CD11b+macrophage population is different from the classically defined inflammatory Gr1+CCR2+CX3CR1 macrophages and Gr1-CCR2-CX3CR1 tissue macrophages [62] and is also distinct from other recently identified macrophage populations in the primary tumor microenvironment such as myeloid suppresso…”
BackgroundTumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 1×
“This distinct phenotypes give further support to the notion of the tumor microenvironment educating the recruited macrophages to give functions that are advantageous to the growing tumor cells [66].”
BackgroundSelf-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“To test the hypothesis that macrophage dependency is a general phenomena for breast cancer pulmonary metastasis, experimental metastasis assays were performed in nude mice using the metastatic variants of MDA-231 human breast cancer cell lines, 3475 and 4173 (kind gifts from Dr. Joan Massague (MSKCC, New York)”
MethodMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 3×
“In part, this tumor promotion by macrophages is due to their role in regulating angiogenesis [45] and to their ability to enhance tumor cell motility, invasion and intravasation (reviewed in [11]).”
BackgroundSelf-citationParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256 · cited 1×
“Studies in primary tumors however, have also revealed major roles for the microenvironment in modulating malignancy including significant roles for resident cells such as fibroblasts and adipocytes, as well as haematopoietic cells [8,9,10,11,12,13].”
Background
Cited by
Items 301–400 of 674
Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer
No, J. H., Moon, J. M., Kim, K., & Kim, Y.-B. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000349892 · Cited by 49
ST2 as checkpoint target for colorectal cancer immunotherapy
der Jeught, K. V., Sun, Y., Fang, Y., Zhou, Z., Jiang, H., Yu, T., Yang, J., Kamocka, M. M., So, K. M., Li, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136073 · Cited by 48
Li, S., Ji, J., Zhang, Z., Peng, Q., Hao, L., Guo, Y., Zhou, W., Cui, Q., & Shi, X. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03861-0 · Cited by 52
“Therefore, CCL-2 is chemotactic for macrophages and plays a role in the recruitment process [37].”
BackgroundTham, M., Khoo, K., Yeo, K. P., Kato, M., Prévost‐Blondel, A., Angeli, V., & Abastado, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3127 · Cited by 50
“Macrophages have previously been reported to regulate the metastatic process, promoting metastatic phenotypes in tumor cells [31], and regulating both intravasation of tumor cells into blood vessels [32] and their extravasation at the metastatic site [33].”
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages
Castells, M., Thibault, B., Mery-Lamarche, E., Golzio, M., Pasquet, M., Hennebelle, I., Bourin, P., Mirshahi, M., Delord, J. P., Querleu, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.020 · Cited by 49
Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases
Rippaus, N., Taggart, D. J., Williams, J. M., Andreou, T., Wurdak, H., Wronski, K., & Lorger, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9445 · Cited by 52
CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis
Beffinger, M., de Lara, P. T., Tugues, S., Vermeer, M., Montagnolo, Y., Ohs, I., Cecconi, V., Lucchiari, G., Gagliardi, A., Misljencevic, N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97792 · Cited by 45
“Discussion Tumor-associated, CSF1R-dependent macrophages promote tumor progression, restrict antitumor immunity, and support tumor cells during all stages of the metastatic cascade (13, 32).”
BackgroundLong-Chain Fatty Acid Analogues Suppress Breast Tumorigenesis and Progression
Gluschnaider, U., Hertz, R., Ohayon, S., Smeir, E., Smets, M., Pikarsky, E., & Bar‐Tana, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0385 · Cited by 52
“Cell cultures MMTV-PyMT primary cells were isolated from 16-week-old MMTV-PyMT mice as described previously (25).”
Lin, G., Peng, J.-W., Liu, D., Xiao, J., Chen, Y., & Chen, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2362-6 · Cited by 46
“macrophages subside metastatic cell seeding efficiency, suggesting that macrophages may accelerate seeding metastasis [14, 15].”
BackgroundThe role of the immune system in brain metastasis.
Leibold, A. T., Monaco, G. N., & Dey, M. (2019) · PubMed · Cited by 54
Tham, M., Tan, K. W., Keeble, J., Wang, X., Hubert, S., Barron, L., Tan, N. S., Kato, M., Prévost‐Blondel, A., Angeli, V., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2482 · Cited by 51
Chen, E. P., Markosyan, N., Connolly, E., Lawson, J. A., Li, X., Grant, G. R., Großer, T., FitzGerald, G. A., & Smyth, E. M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu053 · Cited by 48
“Indeed, depletion of macrophages through Csfop/ Csfop mice, or treatment with liposome-encapsulated clondronate, led to a delayed histological progression to malignancy in a spontaneous mammary tumor model (13,64,65).”
BackgroundThe Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
Hansell, C. A. H., Fraser, A. R., Hayes, A. J., Pingen, M., Burt, C. L., Lee, K. M., Medina‐Ruiz, L., Brownlie, D., MacLeod, M. K. L., Burgoyne, P., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800131 · Cited by 45
“For example, our data show that unlike other models (9, 38, 39), CCR2-dependent macrophage accumulation at sites of metastatic cell extravasation is not essential for tumor development in the B16F10 model.”
ResultGui, P., Ben-Neji, M., Belozertseva, E., Dalenc, F., Franchet, C., Gilhodes, J., Labrousse, A. M., Bellard, E., Golzio, M., Poincloux, R., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0746 · Cited by 46
Ma, B., Wells, A. H., & Clark, A. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.021 · Cited by 52
“Those from the myeloid lineage (MAMs and MDSCs) appear important for promoting the colonization and survival of DTCs [97, 102].”
BackgroundGiurisato, E., Lonardi, S., Telfer, B., Lussoso, S., Risa-Ebrí, B., Zhang, J., Russo, I., Wang, J., Santucci, A., Finegan, K. G., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2416 · Cited by 41
“Lung macrophages from erk5 and LysM-Cre;erk5 na€ ve and B16F10-bearingmicewere subsequently analyzed byflowcytometry to distinguish interstitial (infiltrating) from alveolar (resident) macrophages based on different level of expression of CD11b and Cd11c markers (27, 28).”
BackgroundNanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy
Zhao, Y., Mamuti, M., An, H., Fang, X., Zhao, Y., & Wang, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120552 · Cited by 47
Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
Dong, Y., Wan, Z., Gao, X., Yang, G., & Liu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609762 · Cited by 47
Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages
Reis-Sobreiro, M., da Mota, A. T., Jardim, C., & Serre, K. (2021) · Cells · doi:10.3390/cells10092364 · Cited by 46
“These findings led to the definition of metastasis-associated macrophages (MAMs) suited to promote breast cancer dissemination [97].”
BackgroundHamilton, M. J., Bosiljcic, M., LePard, N. E., Halvorsen, E. C., Ho, V. W., Banáth, J. P., Krystal, G., & Bennewith, K. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300096 · Cited by 42
“Moreover, it has been suggested that Mfs play a critical role in facilitating tumor cell migration out of the primary tumor, entry into blood or lymph vessels, and seeding into distant sites (13).”
BackgroundWaldowska, M., Bojarska-Junak, A. A., & Roliński, J. (2017) · Central European Journal of Immunology · doi:10.5114/ceji.2017.69361 · Cited by 44
Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates
Aderibigbe, B., Aderibigbe, I., & Popoola, P. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics9010002 · Cited by 39
“tes are classified as stable pyrophosphon te analogues [38].”
Backgroundde León, U. A.-P., Vázquez-Jiménez, A., Matadamas-Guzman, M. L., Pelayo, R., & Reséndis-Antonio, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642842 · Cited by 46
“Several strategies focus on diminishing the recruitment of macrophages to the tumor site, showing the limitation of tumor vascularization and metastasis in mouse models (64).”
BackgroundmiR-155–Deficient Bone Marrow Promotes Tumor Metastasis
Yu, F., Jia, X., Du, F., Wang, J., Wang, Y., Ai, W., & Fan, D. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0686 · Cited by 46
“Recent ex vivo imaging studies of metastatic lungs showed that macrophages were recruited toward extravasating tumor cells and that depletion of these macrophages dramatically reduced the seeding and extravasation efficiency and the subsequent survival of tumor cells (4).”
BackgroundInfluentialZhou, N., Zhang, Y., Zhang, X., Lei, Z., Hu, R., Li, H., Mao, Y., Wang, X., Irwin, D. M., Niu, G., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160611966 · Cited by 45
“Removal of macrophages from many tumor models slowed the rate of tumor progression to the most malignant stage and reduced the rate of metastasis [9,10].”
BackgroundMyeloid cell diversification and complexity: an old concept with new turns in oncology
Chioda, M., Peranzoni, E., Desantis, G., Papalini, F., Falisi, E., Solito, S., Mandruzzato, S., & Bronte, V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9268-1 · Cited by 47
“Interestingly, the macrophage population recruited to the metastatic lung is different from the one normally residing in the same tissue; in fact, in pulmonary metastasis CD11bGr1 macrophages with a F4/ 80CSF-1RCX3CR1CCR2VEGFR1 distinct phenotype were absent in normal lung [82], thus re-enforcing the idea that tumour-…”
BackgroundZhang, Y., Hughes, K. R., Raghani, R. M., Ma, J. A., Orbach, S. M., Jeruss, J. S., & Shea, L. D. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120666 · Cited by 43
“Diseaseinduced cell types found at the primary tumor or metastatic niche include inflammatory monocytes (CD11b+ Ly6C-hi cells in mice), tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs).”
BackgroundInfluentialLoric, S., Denis, J. A., Desbène, C., Sabbah, M., & Conti, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087208 · Cited by 49
Modeling the inhibition of breast cancer growth by GM-CSF
Szomolay, B., Eubank, T. D., Roberts, R. D., Marsh, C. B., & Friedman, A. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.03.024 · Cited by 43
Haegel, H., Thioudellet, C., Hallet, R., Geist, M., Menguy, T., Pogam, F. L., Marchand, J., Toh, M., Duong, V., Calcei, A., et al. (2013) · mAbs · doi:10.4161/mabs.25743 · Cited by 36
“Once at the tumor site, TAMs mediate the angiogenic switch,(17) and they facilitate tumor cell extravasation and metastasis.(18,19) It is now recognized that TAMs can represent the most abundant immunosuppressive cell population in the tumor microenvironment, recruited by CSF-1 and MCP-1 (CCL2).”
BackgroundStem-like features of cancer cells on their way to metastasis
Gkountela, S., & Aceto, N. (2016) · Biology Direct · doi:10.1186/s13062-016-0135-4 · Cited by 44
“Alternatively, CTC-associated platelets can release adenine nucleotides and facilitate extravasation by inducing an opening at the endothelial barrier [77], while macrophages that bind to CTCs can promote tissue remodelling and help extravasation through capillary walls in the lung [78].”
BackgroundJaiswal, R., Johnson, M. S., Pokharel, D., Krishnan, S. R., & Bebawy, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3102-2 · Cited by 47
“In the tumour they constitute a distinct macrophage population that mediates cancer cell extravasation, establishment and growth [49, 50].”
Small-Molecule CSF1R Inhibitors as Anticancer Agents
Xun, Q., Wang, Z., Hu, X., Ding, K., & Lu, X. (2019) · Current Medicinal Chemistry · doi:10.2174/1573394715666190618121649 · Cited by 43
Tuit, S., Salvagno, C., Kapellos, T. S., Hau, C., Seep, L., Oestreich, M., Klee, K., de Visser, K. E., Ulas, T., & Schultze, J. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.067 · Cited by 42
Raskov, H., Orhan, A., Salanti, A., & Gögenür, I. (2020) · International Journal of Cancer · doi:10.1002/ijc.32820 · Cited by 41
Navin, I., Lam, M. T., & Parihar, R. (2020) · Cancers · doi:10.3390/cancers12123871 · Cited by 43
“Additionally, inhibitory tumor-associated macrophages (M2-TAMs), utilizing similar mechanisms to MDSCs, can promote cancer growth and support metastasis [17].”
BackgroundCSF-1R Signaling in Health and Disease: A Focus on the Mammary Gland
Dwyer, A. R., & Pixley, F. J. (2014) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-014-9320-1 · Cited by 41
“Away from the primary tumour, metastatic efficiency is also CSF-1 dependent as CSF-1 supports the survival and proliferation of trophic macrophages necessary for establishment and maintenance of the metastatic niche [83].”
BackgroundTan, K., & Naylor, M. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.876451 · Cited by 48
“This interaction with the endothelium can promote the recruitment of various other cells, such as macrophages, platelets and neutrophils which aid in the successful metastasis of cancer cells (65, 66).”
BackgroundPro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2
Mérino, D., Best, S. A., Asselin-Labat, M.-L., Vaillant, F., Pal, B., Dickins, R. A., Anderson, R. L., Strasser, A., Bouillet, P., Lindeman, G. J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.313 · Cited by 44
Embryonic Stem Cells Promoting Macrophage Survival and Function are Crucial for Teratoma Development
Chen, T., Wang, X., Guo, L., Wu, M., Duan, Z., Lv, J., Tai, W., Renganathan, H., Didier, R., Li, J., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00275 · Cited by 40
“We applied a well-documented approach to deleted macrophages by treating mice with liposome-encapsulated clodronate (Cl-Lip) or control liposomes (PBS-Lip) (43).”
MethodSelf-citationMinimal Residual Disease, Metastasis and Immunity
Badia-Ramentol, J., Linares, J., Gómez‐Llonín, A., & Calon, A. (2021) · Biomolecules · doi:10.3390/biom11020130 · Cited by 44
“Finally, macrophages may also interact with CTCs to further assist them during extravasation [65].”
BackgroundThe multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers
Midavaine, É., Côté, J., & Sarret, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09974-2 · Cited by 40
“The recruitment of stromal and tumor-derived CCL2-dependent inflammatory monocytes into the tumor bed further contributes to endothelial permeabilization [90, 126].”
BackgroundSwierczak, A., & Pollard, J. W. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038026 · Cited by 42
“MAMs are important for metastatic growth as depletion of macrophages resulted in a reduced metastatic load (Qian et al. 2009).”
BackgroundResultSelf-citationBao, B., Thakur, A. B., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., Ali, S. S., Lum, L. G., & Sarkar, F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.002 · Cited by 40
“ed with increased tumor angiogenesis, invasion and metastasis, or poor prognosis in cancer [73,74].”
BackgroundVariations in stromal signatures in breast and colorectal cancer metastases
Webster, J. A., Beck, A. H., Sharma, M., Espinosa, Í., Weigelt, B., Schreuder, A. M., Montgomery, K. D., Jensen, K. C., van de Rijn, M., & West, R. B. (2010) · The Journal of Pathology · doi:10.1002/path.2738 · Cited by 37
Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
Li, X., Chen, L., Peng, X., & Zhan, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.911410 · Cited by 43
“(39)demonstrated in an animal model of breast cancer metastasis, using an intact lung imaging system, that macrophages are required for tumor cell extravasation; more importantly, ablation of this macrophage population resulted in a significant decrease in the rate of tumor cell extravasation, thus inhibiting the grow…”
Enzyme‐Activatable Chemokine Conjugates for In Vivo Targeting of Tumor‐Associated Macrophages
Barth, N. D., van Dalen, F. J., Karmakar, U., Bertolini, M., Mendive‐Tapia, L., Kitamura, T., Verdoes, M., & Vendrell, M. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202207508 · Cited by 37
Hypoxia Inducible Factors-Mediated Inhibition of Cancer by GM-CSF: A Mathematical Model
Chen, D., Roda, J. M., Marsh, C. B., Eubank, T. D., & Friedman, A. (2012) · Bulletin of Mathematical Biology · doi:10.1007/s11538-012-9776-3 · Cited by 41
“We recall the following experimental facts reported in Roda et al. (2011, 2012): (i) GM-CSF stimulates macrophages to secrete large amounts of sVEGFR-1, which Table 2 Model parameter values and reference Parameter Dimensional Dimensionless Reference μc 4.80 × 10−6 s−1 1.20 Breward et al. (2001) μb 4.80 × 10−14 cm3 cel…”
InfluentialTracking Monocytes and Macrophages in Tumors With Live Imaging
Laviron, M., Combadière, C., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01201 · Cited by 39
“CCL2-dependent monocyte recruitment has been strongly implicated in metastatic seeding by experiments utilizing CCL2 blockade or global macrophage depletion (31, 32).”
BackgroundInnate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma
Joseph, A. M., Aiyan, A. A., al-Ramadi, B. K., Singh, S. K., & Kishore, U. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1323198 · Cited by 42
“TAMs inhibit T-lymphocyte responses (113) and secrete cytokines that promote the tumor phenotype and metastasis (73, 114).”
BackgroundCutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms
Otsuka, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133286 · Cited by 38
“A distinct population of CD11b+ macrophages may recognize emigrating tumor cells and assist these cells with the invasion process [74].”
BackgroundMutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., Cho, W. C. S., & Mansoori, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121361 · Cited by 40
Reversing the Tumor Target: Establishment of a Tumor Trap
Najberg, M., Mansor, M. H., Boury, F., Alvarez‐Lorenzo, C., & Garcion, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00887 · Cited by 38
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
Kang, X., Huang, Y., Wang, H., Jadhav, S., Yue, Z., Tiwari, A. K., & Babu, R. J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010061 · Cited by 38
“…however, TAM impairs the efficacy of chemotherapy via including CSF-1 [83], CCL2/CCR2+ axis Chemotherapeutic regents achieved success for decades; however, TAM impairs the efficacy of chemotherapy via factors including CSF-1 [83], CCL2/CCR2+ axis [84], and macrophage inhibitory factor (MIF) [85].”
BackgroundFree Fatty Acid Receptor GPR120 and Pathogenesis of Obesity and Type 2 Diabetes Mellitus
Mo, X., Wei, H., Peng, J., & Tao, Y. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00007-8 · Cited by 38
Long-term High-Resolution Intravital Microscopy in the Lung with a Vacuum Stabilized Imaging Window
Rodríguez-Tirado, C., Kitamura, T., Kato, Y., Pollard, J. W., Condeelis, J. S., & Entenberg, D. R. (2016) · Journal of Visualized Experiments · doi:10.3791/54603 · Cited by 35
Self-citationCathepsin L secretion by host and neoplastic cells potentiates invasion
Dykes, S. S., Fasanya, H. O., & Siemann, D. W. (2019) · Oncotarget · doi:10.18632/oncotarget.27182 · Cited by 35
Shaik, B., Zafar, T., Balasubramanian, K., & Gupta, S. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620999201111155426 · Cited by 38
Rapid Extravasation and Establishment of Breast Cancer Micrometastases in the Liver Microenvironment
Martin, M. D., Kremers, G., Short, K. W., Rocheleau, J. V., Xu, L., Piston, D. W., Matrisian, L. M., & Gorden, D. L. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0551 · Cited by 36
Premetastatic niche: ready for new therapeutic interventions?
Zoccoli, A., Iuliani, M., Pantano, F., Imperatori, M., Intagliata, S., Vincenzi, B., Marchetti, P., Papapietro, N., Denaro, V., Tonini, G., et al. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.656092 · Cited by 38
“Given the contribution of tumorassociated macrophages to the malignant progression and metastasis formation, TAM could contribute to the metastatic progression through the promotion of tumor cell dissemination and the initiation of a permissive premetastatic niche in preferential distant organs [10].”
BackgroundThe role of CD200–CD200R in tumor immune evasion
Liao, K., Bai, X., & Friedman, A. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.03.017 · Cited by 39
The role of macrophages in bone metastasis
Vasiliadou, I., & Holen, I. (2013) · Journal of bone oncology · doi:10.1016/j.jbo.2013.07.002 · Cited by 37
“In addition, the growth of pre-formed metastatic nodules was also inhibited by the depletion of macrophages [43].”
BackgroundControl of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes
Hara, T., Nakaoka, H. J., Hayashi, T., Mimura, K., Hoshino, D., Inoue, M., Nagamura, F., Murakami, Y., Seiki, M., & Sakamoto, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703171114 · Cited by 42
“As previously reported (5, 25), all tumor cells were surrounded by CD31-positive lung capillaries in both genotypes at 1 h (Fig.”
Contribution of Macrophages and T Cells in Skeletal Metastasis
Mendoza‐Reinoso, V., McCauley, L. K., & Fournier, P. G. J. (2020) · Cancers · doi:10.3390/cancers12041014 · Cited by 37
“Various studies have demonstrated that liposomes containing clodronate are taken up by macrophages which reduced macrophage tumor infiltration in bone and lung metastasis inhibiting metastasis progression in animal models [4,94,162].”
BackgroundMierke, C. T. (2024) · Biomolecules · doi:10.3390/biom14020184 · Cited by 34
Intravital imaging of metastasis in adult Zebrafish
Benjamin, D. C., & Hynes, R. O. (2017) · BMC Cancer · doi:10.1186/s12885-017-3647-0 · Cited by 35
“Studies of events at the metastatic site have indicated that dynamic interactions between tumor cells, platelets [4, 5], leukocytes [6, 7], and endothelial cells [8] are key in regulating the formation of metastases.”
BackgroundHillers‐Ziemer, L. E., McMahon, R. Q., Hietpas, M., Paderta, G., LeBeau, J., McCready, J., & Arendt, L. M. (2020) · Cancers · doi:10.3390/cancers12020502 · Cited by 33
“Within the tumor microenvironment, TAMs have been shown to establish niches within tumors conducive for CSC expansion [12–14], enhance angiogenesis and metastasis [15,16], and suppress tumor cell responses to different types of chemotherapy [17].”
BackgroundBrownlie, D., Doughty-Shenton, D., Soong, D. Y. H., Nixon, C., Carragher, N. O., Carlin, L. M., & Kitamura, T. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001740 · Cited by 35
Discovering Macrophage Functions Using In Vivo Optical Imaging Techniques
Li, Y., & Liu, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00502 · Cited by 38
“It has been reported that there is a distinct population of macrophages recruited to the distant metastatic sites, which promotes the extravasation, seeding and persistent growth of tumor cells (114).”
BackgroundDeciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer
Borges, V. F., Elder, A. M., & Lyons, T. R. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00227 · Cited by 34
“Together, these findings indicate that the CD11b+ “involution macrophages” may either stimulate lymphangiogenesis through release of pro-lymphangiogenic cytokines or through expression of lymphatic markers and incorporation into existing lymphatics; evidence for both has been published in models of inflammation and ca…”
BackgroundThe Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity
Fico, F., & Santamaria‐Martínez, A. (2020) · Cancers · doi:10.3390/cancers12123863 · Cited by 35
“Indeed, macrophages in the primary and the secondary site are known to possess different traits [73,74].”
Macrophages in multiple myeloma: key roles and therapeutic strategies
Opperman, K. S., Vandyke, K., Psaltis, P. J., Noll, J. E., & Zannettino, A. C. W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09943-1 · Cited by 35
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Zhong, C. F., Li, Y., Yang, J., Jin, S., Chen, G., Li, D., Fan, X., & Lin, H. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.589680 · Cited by 37
“TAMs promote tumor progression through angiogenesis, tumor cell invasion, and metastasis (39).”
BackgroundCXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases
Butler, K. L., Clancy‐Thompson, E., & Mullins, D. W. (2017) · Scientific Reports · doi:10.1038/srep45593 · Cited by 42
“Metastatic engraftment of tumors, including lung metastases, has been shown to require accumulation of tumor-associated monocytes/macrophages in lung 3,5 and tumor cell expression of CXCR3 12–18, 20, 21 .”
Macrophages in Cancer and Infectious Diseases: The ‘Good‘ and the ‘Bad‘
Porta, C., Riboldi, E., Totaro, M. G., Strauss, L., Sica, A., & Mantovani, A. (2011) · Immunotherapy · doi:10.2217/imt.11.116 · Cited by 38
Ren, Z., Xu, Z., Chang, X., Liu, J., & Xiao, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107218 · Cited by 34
Arreola, M. I. P., Moreno-Méndoza, N., Castro, K. E. N., Mendoza, M. S., Pérez‐Torres, A., Garay-Canales, C. A., & Morales‐Montor, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052523 · Cited by 32
“This work demonstrated the relevant relationship between VEGFR and metastasisassociated macrophages (MAMs), proving that this population is firmly implicated in the tropism of lung metastasis in this disease [56,57].”
BackgroundRole of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape
Sudhakaran, M., & Doseff, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065086 · Cited by 32
“Consistently with these observations, chemical or genetic ablation of macrophages resulted in delayed tumor growth and an improved response to therapy [7].”
BackgroundEstko, M., Baumgartner, S., Urech, K., Kunz, M., Regueiro, U., Heusser, P., & Weissenstein, U. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0650-3 · Cited by 37
“Depending on the specific tumour microenvironment, TAMs can exert pro-tumorigenic functions such as metastatic seeding, tumour growth and angiogenesis as well as tumour suppressing activity [7,46,47].”
BackgroundMacrophages and NF-κB in Cancer
Lawrence, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_100 · Cited by 37
Permissive role of endothelin receptors in tumor metastasis
Said, N. A., & Theodorescu, D. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.03.040 · Cited by 32
“Interestingly, the IL-6, MCP-1/CCL2, COX-2, and MMPs induced by ET-1 are also known to breach the lung vasculature and enable extravasation of cancer cells on dissemination of these cells to the lungs (Qian et al., 2009; Gupta and Massague, 2006; Gupta et al., 2007; Mantovani, 2009).”
BackgroundThe significance of macrophage phenotype in cancer and biomaterials
Bygd, H. C., Forsmark, K. D., & Bratlie, K. M. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0041-2 · Cited by 34
“A recent study has shown that TAMs play an important role in controlling the survival, migration and growth of metastatic cells to these niches [31].”
Influence of the Tumor Microenvironment on Angiogenesis
Payne, S. J., & Jones, J. L. (2011) · Future Oncology · doi:10.2217/fon.11.13 · Cited by 32
The Epigenetic landscape of Circulating tumour cells
Vasantharajan, S. S., Eccles, M. R., Rodger, E. J., Pattison, S. T., McCall, J. L., Gray, E. S., Calapre, L., & Chatterjee, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188514 · Cited by 31
Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics
Guerra, E., Pietro, R. D., Basile, M., Trerotola, M., & Alberti, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010405 · Cited by 32
“Consistent, liposome-encapsulated clodronate (dichloromethylene diphosphonate) showed effectiveness at both depleting TAM and reducing metastatic burden [118].”
BackgroundRodríguez-Tirado, C., Entenberg, D. R., Li, J., Qian, B., Condeelis, J. S., & Pollard, J. W. (2022) · Cancers · doi:10.3390/cancers14174336 · Cited by 35
“In vitro assays that mimic extravasating tumor cell transendothelial migration (eTEM) at distant sites have been useful for identifying the signaling pathways by which macrophages promote extravasation in vivo activities with high fidelity (Figure 1A) [5,16,39].”
BackgroundMethodSelf-citationFridrichová, I., Kalinkova, L., & Čierniková, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012141 · Cited by 32
Habib, S., Osborn, G., Willsmore, Z. N., Chew, M. W., Jakubow, S., Fitzpatrick, A., Wu, Y., Sinha, K., Lloyd-Hughes, H., Geh, J. L. C., et al. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2326626 · Cited by 35
“Macrophages have been shown to assist tumor cells attach and extrude through vessel walls, and loss of macrophages has therefore been shown to dramatically decline the extravasation rate with a co-incidence failure of metastasis [85].”
BackgroundChen, D., Bobko, A. A., Gross, A. C., Evans, R., Marsh, C. B., Khramtsov, V. V., Eubank, T. D., & Friedman, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107511 · Cited by 31
“lc 1:6 | 10 s [57,58]”
Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis
Sarvi, S., Patel, H., Li, J., Dodd, G. L., Creedon, H., Muir, M., Ward, J. L., Dawson, J. C., Lee, M. W., Culley, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1518 · Cited by 35
Self-citationA double agent in cancer: Deciphering macrophage roles in human tumors
Ruhrberg, C., & Palma, M. D. (2010) · Nature Medicine · doi:10.1038/nm0810-861 · Cited by 32
Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis
Roblek, M., Călin, M., Schlesinger, M., Stan, D. L., Zeisig, R., Simionescu, M., Bendas, G., & Borsig, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.055 · Cited by 29
“Depletion of circulating inflammatory monocytes by clodronate-loaded liposomes was previously shown to severely affect pulmonary seeding of tumor cells [25].”
Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis
Jiang, D. G., & Lim, S. Y. (2016) · Cancer Microenvironment · doi:10.1007/s12307-016-0181-6 · Cited by 31
“TAMs do not produce IL-12 and consequently, do not recruit the cytotoxic responses of natural killer and TH1 cells.”
BackgroundInfluentialStimulating natural killer cells to protect against cancer: recent developments
Gillgrass, A. E., & Ashkar, A. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.102 · Cited by 32
Shibuya, T., Kamiyama, A., Sawada, H., Kikuchi, K., Maruyama, M., Sawado, R., Ikeda, N., Asano, K., Kurotaki, D., Tamura, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663115 · Cited by 32
“The depletion of CD11b macrophages reduces lung metastasis of breast cancer cells (13).”
BackgroundApplication of Microfluidic Systems for Breast Cancer Research
Frankman, Z. D., Jiang, L., Schroeder, J. A., & Zohar, Y. (2022) · Micromachines · doi:10.3390/mi13020152 · Cited by 32
Changes in Pulmonary Microenvironment Aids Lung Metastasis of Breast Cancer
Wu, M., Liang, Y., & Zhang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860932 · Cited by 31
“At metastatic sites a distinct population of metastasis associated macrophages promoted tumor cell extravasation, seeding and persistent growth (101).”
BackgroundInfluencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
Adams, R., Osborn, G., Mukhia, B., Laddach, R., Willsmore, Z. N., Chenoweth, A. M., Geh, J. L. C., Ross, A. D. M., Healy, C., Barber, L. D., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2127284 · Cited by 32
A microfluidic platform for modeling metastatic cancer cell matrix invasion
Blaha, L. C., Zhang, C., Cabodi, M., & Wong, J. Y. (2017) · Biofabrication · doi:10.1088/1758-5090/aa869d · Cited by 31
Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis
Ren, X., Song, M. L., Liu, X., & He, W. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02465-w · Cited by 31
“VEGF released by metastasis-associated macrophages (MAMs) can induce an increase in vascular permeability [63]which promotes CTCs extravasation (Table 2).”
Metadata
- Authors
- Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W.
- Affiliations
- Albert Einstein College of Medicine (US)
- Churchill Hospital (GB)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Pollard, Jeffrey W.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-10
- Volume
- 4
- Issue
- 8
- Pages
- e6562
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2721818
- OpenAlex
- W2117776343
- Cited by
- 664
- References
- 70
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 26 · 2023: 30 · 2022: 50 · 2021: 60 · 2020: 43 · 2019: 45 · 2018: 49 · 2017: 39 · 2016: 38 · 2015: 44 · 2014: 38 · 2013: 48 · 2012: 42
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (PO1#CA100324)
- National Cancer Institute (P01CA100324, R01CA094173, P30CA013330)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, breast cancer metastasis, tumor cell extravasation, lung metastasis, metastatic seeding, metastatic growth, macrophage depletion, tumor microenvironment, therapeutic target
- MeSH terms
- Animals, Cell Division, Disease Models, Animal, Female, Macrophages, Mammary Neoplasms, Experimental, Neoplasm Metastasis, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.